Table 2 Results in regard to active and remission phases of the disease.

Age

41.22 ± 9.50

n = 74

32.96 ± 7.80

n = 26

0.0001

Disease duration (years)

9.5 (5.0-15.0)

n = 74

6.5 (4.0-12.0)

n = 26

0.046

ESR (1 h)

9.0 (6.0-17.0)

n = 73

27.0 (11.5-49.5)

n = 25

< 0.0001

CRP (mg/L)

0.22 (0.10-0.80)

n = 73

2.70 (1.02-6.20)

n = 25

< 0.0001

Leukocyte (10³/mm³)

7100 (5850-8450)

n = 73

9000 (7200-11800)

n = 25

0.004

TNF-α (pg/mL)

3.63 (1.99-5.26)

n = 66

1.99 (1.34-3.90)

n = 16

0.060

IL-18 (pg/mL)

280.0 (202.0-379.0)

n = 74

213.4 (171.5-306.7)

n = 26

0.040

MPO (U/mg protein)

3.67 (1.61-5.76)

n = 73

4.81 (2.08-7.21)

n = 20

0.339

e-TBARS (nmol/g Hb)

29.2 (26.0-33.9)

n = 74

26.6 (22.4-29.9)

n = 26

0.042

e-SOD (U/gHb)

646.1 (406.9-1069)

n = 74

532.3 (437.9-970.0)

n = 25

0.429

e-CAT (U/gHb)

5122 (4510-5952)

n = 75

4749 (4235-5705)

n = 26

0.432

AOA (%)

40.6 (30.2-50.3)

n = 66

44.6 (37.4-52.3)

n = 23

0.267

FRAP (μmol/L)

775.9 (692.5-951.2)

n = 73

737.1 (625.0-839.8)

n = 26

0.112

TEAC (Trolox equivalents)

4.68 (4.20-5.10)

n = 74

4.70 (4.11-5.26)

n = 26

0.867